Brief: Cullinan Therapeutics Q4 Operating Expenses USD 55.259 Million
Mar 10 (Reuters) - Cullinan Therapeutics Q4 net income USD -50.713 million. Q4 operating income USD -55.259 million vs. IBES estimate USD -56.5 million Q4 pretax profit USD -50.713 million vs. IBES estimate USD -51.5 million